Advanced search
Publication Cover
Scandinavian Journal of Primary Health Care Volume 34, 2016 - Issue 3
Submit an article Journal homepage
987
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Contacting dropouts from type 2 diabetes care in public primary health care: description of the patient population

Timo KauppilaDepartment of General Practice and Primary Healthcare, HUS Institute of Clinical Medicine, University of Helsinki, Helsinki, Finland; ;Social and Health Bureau of the City of Vantaa, Health Centre of the City of Vantaa, Vantaa, Finland; Correspondence[email protected] [email protected]
,
Merja K. LaineDepartment of General Practice and Primary Healthcare, HUS Institute of Clinical Medicine, University of Helsinki, Helsinki, Finland; ;Social and Health Bureau of the City of Vantaa, Health Centre of the City of Vantaa, Vantaa, Finland;
,
Mikko HonkasaloDepartment of General Practice and Primary Healthcare, HUS Institute of Clinical Medicine, University of Helsinki, Helsinki, Finland; ;Health Centre of Nurmijärvi, Nurmijärvi, Finland;
,
Marko RainaSocial and Health Bureau of the City of Vantaa, Health Centre of the City of Vantaa, Vantaa, Finland;
&
Johan G. ErikssonDepartment of General Practice and Primary Healthcare, University of Helsinki, Helsinki University Hospital, Helsinki, Finland
Pages 267-273 | Received 18 Jun 2015, Accepted 11 Apr 2016, Published online: 12 Jul 2016

References

  • Kangas T, Aro S, Koivisto VA, et al. Structure and costs of health care of diabetic patients in Finland. Diabetes Care. 1996;19:494–497.
  • ADA. Standards of medical care in diabetes–2015: summary of revisions. Diabetes Care. 2015;38Suppl:S4.
  • Graber AL, Davidson P, Brown AW, et al. Dropout and relapse during diabetes care. Diabetes Care. 1992;15:1477–1483.
  • Gucciardi E. A systematic review of attrition from diabetes education services: strategies to improve attrition and retention research. Can J Diabetes. 2008;32:53–65.
  • Fullerton B, Erler A, Pohlmann B, et al. Predictors of dropout in the German disease management program for type 2 diabetes. BMC Health Serv Res. 2012;12:8.
  • Simmons D, Fleming C. Prevalence and characteristics of diabetic patients with no ongoing care in South Auckland. Diabetes Care. 2000;13:1791–1793.
  • Pajunen P, Laatikainen T, Sundvall J, et al. Diabetespotilaiden hoitotasapaino FINRISKI 2012 -väestötutkimuksessa [How well type 2 diabetic individuals reach their treatment goals: FINRISK 2012 study]. Finnish Med J. 2014;32:1705–1709.
  • Valle T, Eriksson J, Peltonen M, et al. Diabeetikkojen hoitotasapaino Suomessa vuosina 2009-2010 [Glycaemic control of diabetic patients in Finland in 2009–2010]. DEHKO-Raportti. 2010;5.
  • Tsujimura Y, Takahashi Y, Ishizaki T, et al. Predictors of hyperglycaemic individuals who do not follow up with physicians after screening in Japan: a cohort study. Diabetes Res Clin Pract. 2014;105:176–184.
  • Billimek J, Malik S, Sorkin DH, et al. Understanding disparities in lipid management among patients with type 2 diabetes: gender differences in medication nonadherence after treatment intensification. Women's Health Iss. 2015;25:6–12.
  • Franch-Nadal JP, Mata-Cases M, Vinagre I, et al. Differences in the cardiometabolic control in type 2 diabetes according to gender and the presence of cardiovascular disease: results from the eControl study. Int J Endocrinol. 2014;2014:131709.
  • Franzini L, Ardigo D, Cavalot FR, et al. Women show worse control of type 2 diabetes and cardiovascular disease risk factors than men: results from the MIND.IT study group of the Italian society of diabetology. Nutr Metab Cardiovasc Dis. 2013;23:235–234.
  • Schroeder EB, Bayliss EA, Daugherty SL, et al. Gender differences in cardiovascular risk factors in incident diabetes. Womens Health Iss. 2014;24:61–68.
  • Ballard DJ, Humphrey LL, Melton LJ, 3rd, et al. Epidemiology of persistent proteinuria in type II diabetes mellitus. Population-based study in Rochester, Minnesota. Diabetes. 1988;37:405–412.
  • Finnish Medicines Agency Fimea and Social Insurance Instititution. Finnish statistic on medicines 2011. 2012.
  • Luijks H, Schermer T, Bor H, et al. Prevalence and incidence density rates of chronic comorbidity in type 2 diabetes patients: an exploratory cohort study. BMC Med. 2012;10:128.
  • Colosia AD, Palencia R, Khan S. Prevalence of hypertension and obesity in patients with type 2 diabetes mellitus in observational studies: a systematic literature review. Diabetes Metab Syndr Obes. 2013;6:327–338.
  • Jacobs MJ, Kleisli T, Pio JR, et al. Prevalence and control of dyslipidemia among persons with diabetes in the United States. Diabetes Res Clin Pract. 2005;70: 263–269.
  • Vos T, Flaxman AD, Naghavi M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the global burden of disease study 2010. Lancet. 2012;380: 2163–2196.
  • Gaede P, Lund-Andersen H, Parving HH, et al. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med. 2008;358:580–591.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.